CN102727837A - Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis - Google Patents
Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis Download PDFInfo
- Publication number
- CN102727837A CN102727837A CN2012102559162A CN201210255916A CN102727837A CN 102727837 A CN102727837 A CN 102727837A CN 2012102559162 A CN2012102559162 A CN 2012102559162A CN 201210255916 A CN201210255916 A CN 201210255916A CN 102727837 A CN102727837 A CN 102727837A
- Authority
- CN
- China
- Prior art keywords
- restrains
- radix
- chinese medicinal
- medicinal formulae
- cholelithiasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis, which comprises the following ingredients: 6-12g of radix paeoniae alba, 3-6g of radix bupleuri, 6-10g of fructus aurantii, 6-12g of rhizoma cyperi, 10-30g of desmodium, 6-10g of radix curcumae, 6-12g of polygonum cuspidatum, 10-15g of endothelium corneum gigeriae galli, 6-12g of raw hawthorn, 10-30g of radix clematidis, 6-15g of raw rhubarb, 10-30g of dark plum, 6-12g of talc and 3-5g of licorice. The traditional Chinese medicine prescription disclosed by the invention is used for treating the cholelithiasis and the chronic cholecystitis; the clinical application effect is significant; both the symptoms and the causes can be treated; the traditional Chinese medicine prescription is safe and reliable; the medicine effects are fully exerted, while no damage is caused to the functions of a kidney, a liver, a spleen and a stomach; and the total therapeutically effective rate reaches 98%.
Description
Technical field
The present invention relates to the Chinese medicinal formulae field, especially relate to the Chinese medicinal formulae of treating cholelithiasis and chronic cholecystitis.
Background technology
Cholelithiasis is meant has calculus in the biliary system, it is comparatively common to suffer from the patient among the crowd.Cholelithiasis can betide gallbladder or bile duct, and closely related with cholecystitis, and both normal reciprocal causations also can take place simultaneously.Cholecystitis can cause that calculus forms, and cholelithiasis Chang Bingfa cholecystitis or cholangitis (comprising obstructive pyogenic cholangitis and gangrenous cholecystitis).
The etiology and pathogenesis of cholelithiasis, the understanding of Chinese and western medicine has nothing in common with each other.Modern medicine thinks to be due to cholesterol metabolism imbalance, biliary tract antibacterial and the parasitic infection.The traditional Chinese medical science is thought that then liver and gall stasis, spleen fortune are lost and is good for, damp and hot stifling, final bile condenses and is stone.Yet the viewpoint of this two aspect is all lost biased, and is comprehensive inadequately.The change of cholelithiasis still be two hang-ups of medical circle with row up to now: it is difficultyization why, is should change and don't damage normal organ and tissue because of medicine; Why difficulty is arranged for it, is because calculus is discharged earlier from bottom to top more from top to bottom.
Summary of the invention
In view of this, be necessary to provide the preferable treatment cholelithiasis of therapeutic effect and the Chinese medicinal formulae of chronic cholecystitis.
The present invention realizes like this; The Chinese medicinal formulae of treatment cholelithiasis and chronic cholecystitis, its prescription constituent is following: the Radix Paeoniae Alba 6-12 grams, Radix Bupleuri 3-6 grams, Fructus Aurantii 6-10 grams, Rhizoma Cyperi 6-12 grams, Herba Lysimachiae 10-30 grams, radix curcumae 6-10 grams, Rhizoma Polygoni Cuspidati 6-12 grams, Endothelium Corneum Gigeriae Galli 10-15 grams, Fructus Crataegi 6-12 grams, Radix Clematidis 10-30 grams, Radix Et Rhizoma Rhei 6-15 grams, Fructus Mume 10-30 grams, Talcum 6-12 grams, Radix Glycyrrhizae 3-5 grams.
As the further improvement of such scheme, said Chinese medicinal formulae is applied as tablet or pill or electuary or capsule particle.
As the further improvement of such scheme, the method for using of said Chinese medicinal formulae may further comprise the steps: said Chinese medicinal formulae is one day used dosage, water proof decoction day 3 times; 10 days is a course of treatment, takes medicine 1-2 courses of treatment.
As the further improvement of such scheme, said Chinese medicinal formulae is one day used dosage, and said Chinese medicinal formulae is used when being processed into tablet or pill or electuary or capsule particle, takes for 3 times in same natural gift.Therefore, the equivalence of the drug effect of the tablet taken for 3 times of same natural gift or pill or electuary or capsule particle is the drug effect of said Chinese medicinal formulae.
The Chinese medicinal formulae of said treatment cholelithiasis and chronic cholecystitis, it is used to treat cholelithiasis and chronic cholecystitis, and clinical practice is evident in efficacy; Treating both the principal and secondary aspects of a disease; Safe and reliable, the effect of giving full play to medicine does not damage Liver and kidney and spleen and stomach function again, and the treatment total effective rate reaches 98%; The opinion of its comprehensive traditional Chinese medical science and modern medicine is effectively treated cholelithiasis and chronic cholecystitis, and therapeutic effect is preferable.
The specific embodiment
In order to make the object of the invention, technical scheme and advantage clearer,, the present invention is further elaborated below in conjunction with embodiment.Should be appreciated that specific embodiment described herein only in order to explanation the present invention, and be not used in qualification the present invention.
The Chinese medicinal formulae of treatment cholelithiasis provided by the invention and chronic cholecystitis, its prescription constituent is following: the Radix Paeoniae Alba 6-12 grams, Radix Bupleuri 3-6 grams, Fructus Aurantii 6-10 grams, Rhizoma Cyperi 6-12 grams, Herba Lysimachiae 10-30 grams, radix curcumae 6-10 grams, Rhizoma Polygoni Cuspidati 6-12 grams, Endothelium Corneum Gigeriae Galli 10-15 grams, Fructus Crataegi 6-12 grams, Radix Clematidis 10-30 grams, Radix Et Rhizoma Rhei 6-15 grams, Fructus Mume 10-30 grams, Talcum 6-12 grams, Radix Glycyrrhizae 3-5 grams.
Said Chinese medicinal formulae is one day used dosage, and water proof decoction day 3 times, day number of drug administration is 15-20 days, and every day is like this.Take for ease, also can said Chinese medicinal formulae be processed into tablet or pill or electuary or capsule particle, take for one day 3 times, when that is to say one day used dosage being processed into tablet or pill or electuary or capsule particle, take for 3 times in same natural gift.
Subsequent Chinese medicinal formulae to treatment cholelithiasis and chronic cholecystitis is done the detail analysis explanation.
(1) determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs
Cholelithiasis is meant has calculus in the biliary system, it is comparatively common to suffer from the patient among the crowd.Cholelithiasis can betide gallbladder or bile duct, and closely related with cholecystitis, and both normal reciprocal causations also can take place simultaneously.Cholecystitis can cause that calculus forms, and cholelithiasis Chang Bingfa cholecystitis or cholangitis (comprising obstructive pyogenic cholangitis and gangrenous cholecystitis).
The etiology and pathogenesis of cholelithiasis, the understanding of Chinese and western medicine has nothing in common with each other.Modern medicine thinks to be due to cholesterol metabolism imbalance, biliary tract antibacterial and the parasitic infection.The traditional Chinese medical science is thought that then liver and gall stasis, spleen fortune are lost and is good for, damp and hot stifling, final bile condenses and is stone.Yet the viewpoint of this two aspect is all lost biased, and is comprehensive inadequately.If can integrate both opinions, integrate and see, its theory then maybe be fairly perfect.
(2) treatment rule
Cholelithiasis blocks the gallbladder bile duct, and obstructed then pain to its pathology and pathogenesis, is controlled suitable: depressed liver-energy dispersing and function of gallbladder promoting, fossil calculus.All medications are all under this rule instructs.
(3) ingredient
The Radix Paeoniae Alba 6-12 grams, Radix Bupleuri 3-6 grams, Fructus Aurantii 6-10 grams, Rhizoma Cyperi 6-12 grams, Herba Lysimachiae 10-30 grams, radix curcumae 6-10 grams, Rhizoma Polygoni Cuspidati 6-12 grams, Endothelium Corneum Gigeriae Galli 10-15 grams, Fructus Crataegi 6-12 grams, Radix Clematidis 10-30 grams, Radix Et Rhizoma Rhei 6-15 grams, Fructus Mume 10-30 grams, Talcum 6-12 grams, Radix Glycyrrhizae 3-5 grams.
Note: (1) this prescription is one day used dosage, Steam by water bath clothes day 3 times;
(2) Herba Lysimachiae is preferably adopted Herba Lysimachiae, than adopting lobule Herba Lysimachiae (be commonly called as, coagulate the gold grass) effect to come well.
(4) Fang Yi resolves
We card is for due to QI stagnation of the liver and galibladder pent-up, biliary tract antibacterial and the parasitic infection.Radix Bupleuri in the side, Rhizoma Cyperi, radix curcumae, Fructus Aurantii etc., but depressed liver-energy dispersing and function of gallbladder promoting, dispelling the stagnated QIization stagnates.Rhizoma Polygoni Cuspidati, Endothelium Corneum Gigeriae Galli, Fructus Crataegi are the article of general fossil, dissolving power a little less than, yet the medicine 5 o'clock mutually of acidity is contained with Radix Clematidis and Fructus Crataegi, Fructus Mume, the Radix Paeoniae Alba etc. in the side, can produce stronger dissolving power, can make big petrochemical industry little, little petrochemical industry.Herba Lysimachiae in the side, Talcum, Radix Et Rhizoma Rhei etc., but removing dampness, diuresis, diarrhea with indigested food road help the discharge of calculus.Even so, the efficacy of a drug that still lacks lifting.Why cholelithiasis is generally acknowledged difficult row by medical circle, is because the route that cholelithiasis is discharged from capsule advances earlier from bottom to top, discharges from the top down again, and process is comparatively tortuous, is " ∧ " font.Can separate this difficult problem this side simply with Fructus Mume, Fructus Mume can impel gallbladder to produce stronger contractility through after digesting and assimilating, and upwards advances the stone in the capsule to the capsule bile duct, upwards to the ductus choledochus extruding, discharges downwards through gastrointestinal tract then again.But the Herba Lysimachiae of Fang Zuzhong, Rhizoma Polygoni Cuspidati, Radix Et Rhizoma Rhei, Fructus Mume heat-clearing and toxic substances removing antiinflammatory, especially Radix Et Rhizoma Rhei just have stronger antibacterial action to ten various bacteria simply, so we can be used for treating cholecystitis again.The Radix Et Rhizoma Rhei of Fang Zuzhong and Fructus Mume two flavor Chinese medicines are the medicine that restricts each other.Fructus Mume can be restrained high the rushing down suddenly of Radix Et Rhizoma Rhei and exerted oneself, and Radix Et Rhizoma Rhei also can be restrained the relieving diarrhea with astringents power of Fructus Mume conversely, and helps under the row of calculus.But Fang Zuzhong is with the Radix Paeoniae Alba and Radix Glycyrrhizae 5 relieving spasm to stop pain mutually, can alleviate the smooth muscle spasm of gallbladder and bile duct and the biliary colic that causes.
(5) therapeutic domain
Cholelithiasis; Chronic cholecystitis (no thermal image).
(6) points for attention
It is common bile duct silt particle property calculus that this medicament is not suitable for hepatic duct, this sandstone can continuously produce and arrange not to the utmost, its cause of disease is fully clear and definite as yet.
(7) clinical efficacy
Treatment gallstone patients 43 examples, 42 examples of fully recovering, another example are after discharging the about sand shape of ml more than 20 calculus, and it is uncomfortable still to feel upper right abdomen, and the result excises one's gallbladder and takes out two like calculus as the Fructus Jujubae, and total effective rate is 98%.Clinical practice we more than 20 year, minimum taking medicine 10 days taken medicine at most 20 days, and not seeing has any untoward reaction, generally takes medicine and existingly sees that calculus discharged in second day.
Connect in the 43 routine gallstone patients of controlling above-mentioned, once took XIAOYAN LIDAN PIAN, Jindan sheet etc. mostly to some extent, but curative effect a little less than.
(8) medicine is made and instructions about how to take medicine
Medicine was all crude drug in whole among we's group was listed, needed the Steam by water bath clothes.For making things convenient for the patient to take, under the bioprocess technology, manufacture pill, tablet, electuary, capsule particle agent etc. in modern times.For guaranteeing that curative effect preferably processes electuary, the dosage that every day is required is packed as 3 bags, day clothes 3 times, and boiled water is taken after mixing it with water, and 10 days is a course of treatment, generally takes medicine 1-2 courses of treatment.
The above is merely preferred embodiment of the present invention, not in order to restriction the present invention, all any modifications of within spirit of the present invention and principle, being done, is equal to and replaces and improvement etc., all should be included within protection scope of the present invention.
Claims (4)
1. treat the Chinese medicinal formulae of cholelithiasis and chronic cholecystitis, its constituent of writing out a prescription is following: the Radix Paeoniae Alba 6-12 restrains, Radix Bupleuri 3-6 restrains, Fructus Aurantii 6-10 restrains, Rhizoma Cyperi 6-12 restrains, Herba Lysimachiae 10-30 restrains, radix curcumae 6-10 restrains, Rhizoma Polygoni Cuspidati 6-12 restrains, Endothelium Corneum Gigeriae Galli 10-15 restrains, Fructus Crataegi 6-12 restrains, Radix Clematidis 10-30 restrains, Radix Et Rhizoma Rhei 6-15 restrains, Fructus Mume 10-30 restrains, Talcum 6-12 restrains, Radix Glycyrrhizae 3-5 restrains.
2. the Chinese medicinal formulae of treatment cholelithiasis as claimed in claim 1 and chronic cholecystitis is characterized in that, said Chinese medicinal formulae is applied as tablet or pill or electuary or capsule particle.
3. the Chinese medicinal formulae of treatment cholelithiasis as claimed in claim 1 and chronic cholecystitis is characterized in that, the method for using of said Chinese medicinal formulae may further comprise the steps:
Said Chinese medicinal formulae is one day used dosage, Steam by water bath clothes day 3 times;
10 days is a course of treatment, takes medicine 1-2 courses of treatment.
4. according to claim 1 or claim 2 treatment cholelithiasis and the Chinese medicinal formulae of chronic cholecystitis; It is characterized in that; Said Chinese medicinal formulae is one day used dosage, and said Chinese medicinal formulae is used when being processed into tablet or pill or electuary or capsule particle, takes for 3 times in same natural gift.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210255916.2A CN102727837B (en) | 2012-07-23 | 2012-07-23 | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210255916.2A CN102727837B (en) | 2012-07-23 | 2012-07-23 | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102727837A true CN102727837A (en) | 2012-10-17 |
CN102727837B CN102727837B (en) | 2014-04-16 |
Family
ID=46984601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210255916.2A Expired - Fee Related CN102727837B (en) | 2012-07-23 | 2012-07-23 | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102727837B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103263516A (en) * | 2013-05-30 | 2013-08-28 | 刘硕年 | Medicine for treating cholecystitis |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1334119A (en) * | 2001-07-26 | 2002-02-06 | 王继平 | Litholysizing bear gall powder |
CN101062372A (en) * | 2007-05-30 | 2007-10-31 | 仵赈倜 | Chinese herbal medicine preparation for dissolving hepatobiliary system calculi |
CN101104069A (en) * | 2007-06-14 | 2008-01-16 | 王寿叶 | Traditional Chinese medicine formula for treating liver (biliary) inflammation |
CN101417029A (en) * | 2008-11-19 | 2009-04-29 | 吉林省中医药科学院 | Medicine composition for treating cholecystitis |
CN101549113A (en) * | 2008-04-03 | 2009-10-07 | 北京中科仁和科技有限公司 | Traditional Chinese medicine composition for treating urinary system stones and preparation method thereof |
CN102579980A (en) * | 2012-03-02 | 2012-07-18 | 张国栋 | Medicine for treating calculus in hepatobiliary system |
-
2012
- 2012-07-23 CN CN201210255916.2A patent/CN102727837B/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1334119A (en) * | 2001-07-26 | 2002-02-06 | 王继平 | Litholysizing bear gall powder |
CN101062372A (en) * | 2007-05-30 | 2007-10-31 | 仵赈倜 | Chinese herbal medicine preparation for dissolving hepatobiliary system calculi |
CN101104069A (en) * | 2007-06-14 | 2008-01-16 | 王寿叶 | Traditional Chinese medicine formula for treating liver (biliary) inflammation |
CN101549113A (en) * | 2008-04-03 | 2009-10-07 | 北京中科仁和科技有限公司 | Traditional Chinese medicine composition for treating urinary system stones and preparation method thereof |
CN101417029A (en) * | 2008-11-19 | 2009-04-29 | 吉林省中医药科学院 | Medicine composition for treating cholecystitis |
CN102579980A (en) * | 2012-03-02 | 2012-07-18 | 张国栋 | Medicine for treating calculus in hepatobiliary system |
Non-Patent Citations (5)
Title |
---|
李玄 等: "《胆囊炎 胆石症-患者最想知道什么》", 31 January 2004, 山西科学技术出版社 * |
蔡树涛: "《常见慢性病自然疗法系列-胆囊炎与胆结石》", 31 May 2000, 江西科学技术出版社 * |
邓宝华,戴焕林: "利胆汤合并胆结石治疗仪治疗胆石病88例", 《江苏中医》 * |
陈培琼等: "胆石清片治疗胆石症的临床和实验研究", 《中国中西医结合消化杂志》 * |
韩双平: "利胆排石合剂治疗胆石症70例疗效观察", 《河北中医》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103263516A (en) * | 2013-05-30 | 2013-08-28 | 刘硕年 | Medicine for treating cholecystitis |
CN103263516B (en) * | 2013-05-30 | 2014-11-26 | 刘硕年 | Medicine for treating cholecystitis |
Also Published As
Publication number | Publication date |
---|---|
CN102727837B (en) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102697899A (en) | Traditional Chinese medicine composition for treating osteoarthritis and preparation method thereof | |
CN102813791A (en) | Traditional Chinese medicine composition for treating kidney stone | |
CN104013756B (en) | A kind of Chinese medicine composition for preventing and treating diarrhoea and application thereof | |
CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
CN102038829A (en) | Medicament for treating gastritis and ulcers of stomachs and duodenums | |
CN103656499B (en) | A kind of Traditional Chinese drug mixture treating cystic polyp and preparation method thereof | |
CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
CN104547633B (en) | A kind of Chinese medicine composition for treating cervical spondylopathy and preparation method thereof | |
CN102727837B (en) | Traditional Chinese medicine prescription for treating cholelithiasis and chronic cholecystitis | |
CN103417716B (en) | Hypoglycemic Tongluo tablet for treating diabetic peripheral neuropathy | |
CN104147369A (en) | Traditional Chinese medicine for treating chronic ulcerative colitis | |
CN105687672A (en) | Traditional Chinese medicine composition for treating mastitis and mammary gland hyperplasia and preparation method thereof | |
CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
CN104971302A (en) | Traditional Chinese medicine composition for treating biliary tract ascariasis | |
CN103655849A (en) | Chinese medicinal composition for treating common cold due to wind-cold and preparation method and application thereof | |
CN103520480B (en) | A kind of Chinese medicine composition for the treatment of biliary ascariasis | |
CN105832934A (en) | Traditional Chinese medicine for treating hypertension | |
CN104547923A (en) | Traditional Chinese medicine composition for treating gouty nephropathy and application thereof | |
CN103877348A (en) | Traditional Chinese medicine preparation for treating periostitis and preparation method thereof | |
CN105213927A (en) | A kind of medicine for the treatment of acute enteritis and preparation method thereof | |
CN105288528A (en) | Medicinal liquor for treating spleen-stomach disharmony | |
CN104524045A (en) | Traditional Chinese medicine liquid for treating kidney calculi and urethral calculi | |
CN104147523A (en) | Traditional Chinese medicine preparation for treating cholecystitis | |
CN105213522A (en) | A kind of medicine for the treatment of dysentery | |
CN103463478A (en) | Preparation method of traditional Chinese medicine for treating intemperance type acute neck lymphnoditis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140416 Termination date: 20190723 |
|
CF01 | Termination of patent right due to non-payment of annual fee |